Alerts
Other content recommended for you
- Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS)
- Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study
- Assent as an ethical imperative in the treatment of ADHD
- Stimulant drugs for severe hyperactivity in childhood
- What place for ▼lisdexamfetamine in children and adolescents with ADHD?
- Service use in children aged 6–8 years with attention deficit hyperactivity disorder
- Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
- Childhood attention-deficit/hyperactivity disorder
- Stimulant medication to treat attention-deficit/hyperactivity disorder
- Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial